OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


2005 Individual Investigator Grant Recipient – Xiaolong He

Xiaolong He, Ph.D.
University of Chicago
One Cause of Ovarian Cancer May Lay in Problems with mRNA

Project Summary

Pre-mRNA splicing is an essential cellular process that leads to the generation of mature mRNA’s, which are the templates a cell uses to make our proteins. Defects in pre-mRNA splicing have been shown to be causes of a variety of human diseases. Although it is unclear whether altered pre-mRNA splicing causes cancers, there is mounting evidence showing that altered splicing is associated with and possibly involved in tumor progression and/or metastasis. Based on previous studies and Dr. He’s observations, he plans to study whether changes in pre-mRNA splicing occur during the transformation of human ovarian surface epithelial cells into cancer cells and to test whether modulation of splicing can retard or stop the transformation of the epithelial cells. If the cancerous transformation can be retarded or stopped by manipulating the expression of a protein, called PTB, that affects splicing, then a new therapeutic target for ovarian cancer could be developed.